delete PART 201—LABELING
FDA regulation establishing comprehensive drug labeling requirements, including mandatory disclosure of manufacturer/packer/distributor information, detailed rules for identifying multiple manufacturers, ingredient listings, specific warning statements for allergens like FD&C Yellow No. 5, aspartame, and sulfites, and requirements for prominence and legibility of all label information.
This regulation imposes massive compliance costs on pharmaceutical manufacturers, particularly small businesses, creating barriers to entry and protecting established incumbents. The extremely detailed specifications (e.g., exact warning wording, precise definitions of manufacturing operations) exceed what's necessary for consumer protection and represent regulatory capture. These compliance costs are passed to consumers through higher drug prices—effectively a hidden tax. Moreover, drug labeling regulation violates Tenth Amendment federalism; such matters should be left to states where consumers' diverse preferences can be accommodated through market competition rather than one-size-fits-all federal mandates.